@article{0dce01857e2b4bc79be469dbf2df196e,
title = "Treatment of scleromyxedema with 2-chlorodeoxyadenosine",
abstract = "Scleromyxedema is an unusual skin disease that is characterized by a proliferation of fibroblasts and an accumulation of mucin. Despite experience with multiple forms of therapy, no single agent has proved uniformly beneficial in this condition. We describe a patient with scleromyxedema who was treated successfully with 2-chlorodeoxyadenosine (2-CdA), a purine analog used mainly in the treatment of lymphoproliferative disorders.",
author = "Davis, {Loretta S.} and Salahattin Sanal and Sangueza, {Omar P.}",
note = "Funding Information: ORTHO This article is made possible through an educational grant from the Dermatological Division, Ortho Pharmaceutical Corporation. From the Departments of Medicine a and Pathology,b Medical College of Georgia. Reprint requests: Loretta S. Davis, MD, Department of Medicine (Section of Dermatology), Medical College of Georgia, 1004 Cha-fee Ave., Augusta, GA 30904. Copyright {\textcopyright} 1996 by the American Academy of Dermatology, Inc. 0190-9622/96 $5.00 + 0 16/4/70837",
year = "1996",
month = aug,
doi = "10.1016/S0190-9622(96)90650-7",
language = "English (US)",
volume = "35",
pages = "288--290",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2 II",
}